SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-277030
Filing Date
2022-11-03
Accepted
2022-11-03 17:18:57
Documents
16
Period of Report
2022-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d411212d8k.htm   iXBRL 8-K 28573
2 EX-99.1 d411212dex991.htm EX-99.1 73574
7 GRAPHIC g411212no1.jpg GRAPHIC 15726
8 GRAPHIC g411212no3.jpg GRAPHIC 9087
  Complete submission text file 0001193125-22-277030.txt   306913

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20221103.xsd EX-101.SCH 3144
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20221103_def.xml EX-101.DEF 13953
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20221103_lab.xml EX-101.LAB 23052
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20221103_pre.xml EX-101.PRE 14831
10 EXTRACTED XBRL INSTANCE DOCUMENT d411212d8k_htm.xml XML 5562
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 221359155
SIC: 2836 Biological Products, (No Diagnostic Substances)